The Relationship Between Prior Concussions and Depression Is Modified by Somatic Symptomatology in Retired NFL Athletes

Participants were originally recruited for a study assessing neurologic function in former NFL athletes.¹⁸ Recruitment methods, exclusion criteria, and data-gathering procedures have been described in depth elsewhere.¹⁸ Below, we provide abbreviated methodological details that are pertinent to the current study. The study coordinator obtained consent for participants who met the inclusion or exclusion criteria. Records were deidentified, coded numerically, and imported into an Excel spreadsheet (Microsoft). Institutional review board-approval for this study was obtained (institutional review board number, 0706004996).

With the help of the NFL Players Association (NFLPA), recruitment letters explaining the purpose and nature of the study were mailed to more than 5,000 retired athletes. Recipients interested in participating were asked to call the study coordinator at a confidential telephone number. Once enrolled, some participants voluntarily contacted former teammates to solicit study participation as well. Two athletes (4.4%) in the final cohort independently contacted the study coordinator after hearing about the study from former teammates. The study coordinator also called athletes at random from NFLPA records in order to invite their participation.

The inclusion criteria were former NFL athletes interested in participation, age 60 years or less, who were able to tolerate MRI. The exclusionary criteria were a history of brain surgery; brain tumors; cerebrovascular accidents, such as stroke; multiple sclerosis; seizures that began before entering the NFL (except febrile seizures); HIV or AIDS; nonathletic trauma that resulted in significant head injuries; complicated concussions or mTBI that involved loss of consciousness for more than 1 minute or hospitalization that took place after NFL career; open heart surgery, organ transplant surgery, or carotid artery surgery; cancer-related treatment (e.g., chemotherapy or radiation therapy) that contained the potential for adverse effects on the brain or spinal cord functioning; renal failure requiring dialysis, liver failure, cirrhosis, or request for liver transplant; substance-use-related league suspension, arrest for driving under the influence, or treatment in a rehabilitation facility for drug or alcohol abuse, indicating the presence of significant alcohol or drug abuse in the past or present; current daily use of an illegal drug; and suspected current alcohol dependence disorder, as indicted by daily intake of more than four beers or more than two liquor drinks per day during the past 5 years.

A thorough medical, social, and family history was obtained from each participant. After participants were read the definition of a concussion used by the NFL’s mTBI Committee,¹⁹ a detailed head injury and concussion history was obtained from every participant, including recall of the number of concussions sustained at all levels of play. SRC history was examined as a continuous variable.

A comprehensive battery of self-report inventories was administered and scored by a board-certified neuropsychologist (PhD), who used standardized scoring instructions. The focus of the current study was the BDI-II¹⁵ and the Patient Health Questionnaire (PHQ) results.^20,21 The BDI-II is a frequently used self-report questionnaire for the assessment of clinical depression.^20,21 Participants rated the severity of the 21 depressive symptoms on a four-point scale (0–3). Greater scores indicated higher symptomology. Total scores could range from 0 to 63 and were examined as a continuous variable. Ranges for interpretation of BDI-II total scores include 0–13 (minimal), 14–19 (mild depression), 20–28 (moderate depression), and 29–63 (severe depression).²²

Somatic symptoms were measured using the Patient Health Questionnaire-15 (PHQ-15)²³ and scored using standardized scoring instructions. As part of the full PHQ, originally designed to screen for multiple common mental health disorders in primary care patients,²⁴ the PHQ-15²⁵ is a subscale of a larger instrument that measures commonly experienced somatization or physical complaints. Three items were removed from the original PHQ-15 for the purposes of this study. One was a question about menstrual cramps. Two additional items were removed due to direct overlap with similar BDI-II questions: 1) feeling tired or having low energy, and 2) trouble sleeping. The final 12 items were scored from 0 to 2, with 0 indicating responses of “not bothered” and 2 corresponding with “bothered a lot” by the particular somatic symptom. Total somatic symptom endorsement scores on the adjusted PHQ-15 could range from 0 to 24 and were examined as a continuous variable.

Outliers or extreme values in the data were detected using the outlier labeling rule.²⁶ A moderation analysis was used to investigate the main effects of somatic-related symptoms and SRC history on depressive symptom severity, as well as an interaction effect between SRC history and somatic symptoms.^27,28 Mean centering of the predictor variables was performed in order to reduce likely multicollinearity.^28,29 As part of the moderation analysis, follow-up simple slopes analysis (effect of SRC history on depression at 1 standard deviation below, 1 standard deviation above, and at the mean of somatic symptoms) was performed in order to further investigate the nature of the interaction observed.³⁰ Additionally, the Johnson-Neyman technique was performed to identify the exact threshold at which somatic symptom endorsement influences SRC history and depression scores.³¹

After detecting and removing outliers from the 45 retired NFL athletes who met inclusion or exclusion criteria, 43 (96%) retired athletes were included in the final moderation analysis. Outliers of SRC history (25; N=1) and depression severity (35; N=1) were removed in order to reduce skewness associated with normality assumptions in the data. The retired NFL players in this cohort averaged 8.7 (SD=6.63) prior SRCs. Complete demographic characteristics of the final sample are provided in Table 1. The average total depression score on the BDI-II questionnaire was 9.26 (SD=8.95). The frequency of individual depressive symptom endorsement is provided in Table 2. Of the total sample with BDI-II scores, 29 subjects fell within the minimal depression range (0–13).²² Other depression score classifications across the remaining subjects included nine in the mild,^14–19 three in the moderate,^20–28 and two in the severe ranges.²⁹ Somatic symptom endorsement was robust across items, averaging a total somatic symptom score of 5.35 (SD=3.58) (Table 3). Somatic symptom endorsement was positively correlated with the total number of SRCs, r=0.36, p=0.02.

To test the hypothesis that the relationship between SRC history and depression symptom severity is influenced by somatic symptoms, a hierarchal multiple regression analysis was performed. In the first step, SRC history and somatic symptom scores were included, and they accounted for a significant amount of depressive symptomology in retired NFL athletes, R²=0.47, F=17.70, df=2, 40, p<0.001. This indicates a positive association between somatic symptoms and depression scores, as well as number of concussions and depressive symptoms (i.e., greater somatic symptom endorsement or number of concussions increases likelihood of higher depression scores). Standardized beta coefficients of the two variables in the first entry indicated that somatic symptoms, β=0.53, p<0.001, have nearly twice the effect on depressive symptoms above SRC history, β=0.28, p=0.03. For an increase of one standard deviation in somatic symptom score (3.58), predicted depression symptoms increase by 0.53 of a standard deviation (4.74), whereas an increase of one standard deviation of prior SRC (6.63) increased predicted depressive symptom severity by 0.28 of a standard deviation (2.51).

When the interaction term between SRC history and somatic symptom endorsement was entered into the second step of the regression, it explained a significant increase of variance in depressive symptom severity, ΔR²=0.05, F=5.05, df=1, 39, p=0.03. The overall moderation analysis model containing independent predictors of SRC history, somatic symptom endorsement, and their interaction effect on depression symptom severity was significant, R²=0.52, F=15.71, df=3, 39, p<0.001. Main effects of SRC history, B=0.33, p=0.03, and somatic symptom endorsement, B=1.25, p=0.01, remained significant with the interaction effect included.

A simple slopes analysis revealed that SRC history was not significantly associated with depressive symptom severity for somatic symptom endorsement one standard deviation below the mean, B=0.02, p=0.90 (Table 4). At the mean level of somatic symptom endorsement, SRC history was significantly associated with depressive symptom severity, B=0.33, p=0.03. At levels of one standard deviation above the mean of somatic symptom endorsement, the relationship between SRC history and depressive symptom severity was the strongest, B=0.64, p=0.01 (Figure 1). The Johnson-Neyman technique revealed that the relationship between SRC history and severity of depressive symptoms was significant when total somatic symptom endorsement was 5 or greater on the adjusted PHQ-15, with 51% of the sample falling above this threshold (Table 5).

These results suggest that medical professionals should be especially attentive to a retired athlete’s comorbid medical history and physically related conditions. If a retired athlete reports an extensive history of SRC and somatic or depressive symptomatology, referral to a sports psychiatrist or clinical neuropsychologist is recommended for further assessment of the primary etiology of these symptoms and to differentiate depressive symptoms as purely somatic, psychiatric, or mixed. Additionally, integrated treatment among providers is necessary for both depression and somatic conditions. For example, pharmacological treatment and counseling management of both depression and pain require communication between practitioners.⁴⁷

If somatic symptoms can be mitigated, it is possible that the risk and/or severity of depression may be decreased. In this light, how does one protect against somatic symptom development? A career of playing professional football is sure to have negative musculoskeletal effects that may lead to somatic symptoms. Research into inflammatory mechanisms underlying the complex relationship between head trauma,⁴⁸ musculoskeletal injuries,⁴⁹ somatic symptoms,⁵⁰ depression,^50,51 and neurodegenerative disorders^52,53 is a herculean endeavor, but addressing these physical complaints is a necessity. Our results allow us to conclude that there are moderating factors that can affect the strength and nature of the relationship between SRC and depression. As the scientific community and public interpret the new wave of studies regarding SRC and mTBI in youth, high school, collegiate, and professional athletes, one must aim to account for all variables and not simply interpret a nuanced relationship as the result of SRC alone.

When assessing neurologic function of retired professional athletes, future studies should integrate full medical and psychiatric histories to control for potential confounding variables, in order to gain further insight into the exact mechanism driving this moderated relationship. Moreover, inventories that differentiate somatic symptoms as being psychiatric or medical in origin should also be obtained.⁵⁴ Screening instruments alone may not discern nuances in the complex relationship between depression and SRC history. Given increased effectiveness, as compared with screening instruments,⁵⁵ as well as the nuanced relationship of variables in the current study, clinical neuropsychiatric diagnostic interviews should be employed in order to effectively identify a diagnosis of depression in former athletes. Finally, future efforts should bridge somatic symptomatology with functional measures, such as quality of life.

The current study is not without limitations. First, the lack of a control group prevents concluding whether the influence of somatic symptom endorsement on the relationship between SRC history and self-reported depression is applicable to all athletes or is specific to the current sample of retired NFL athletes. Additionally, the lower response rate (45 of 5,000 letters sent to former players) warrants caution regarding the external validity and generalizability of the study. As highlighted above, the current analysis did not control for physical conditions or diagnoses. Thus, because the true etiology of somatic symptoms was unknown, it is difficult to know whether the moderating effect of somatic symptoms is due to secondary neurological or psychiatric disorders, other physical conditions, or emotional distress. Additionally, the mean depression score of the current sample, 8.7 (SD=6.63), was not clinically significant, as it fell within the minimal symptom range according to standard BDI-II criteria.²² As such, average self-reported depressive symptom scores in the current study should not be interpreted as reflecting clinical depression. The average depression score in the current study and sample is in alignment with self-reported depressive symptom endorsement (8.74 [SD=9.7]) in a nonpsychiatric sample of adults presenting to their primary care physician.⁵⁶ As a related limitation of the study, diagnoses of depression were not confirmed via structured clinical interviews by psychiatric clinicians. Furthermore, comorbid psychiatric diagnoses and symptoms were also not taken into account. Similarly, all SRC histories were self-reported, which is not always representative of true injury history.¹ The self-report nature of SRC has implications for possible confounds related to tendency to overreport SRCs along with depressive and somatic symptoms. More comprehensive measures with symptom validity testing would likely have been useful in detecting this trend.